RGBP
Price:
$0.1508
Market Cap:
$377.63K
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.[Read more]
Industry
Biotechnology
IPO Date
2014-10-06
Stock Exchange
PNK
Ticker
RGBP
According to Regen BioPharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 16.82%. This represents a change of 300.48% compared to the average of 4.20% of the last 4 quarters.
The mean historical ROE of Regen BioPharma, Inc. over the last ten years is 1.36%. The current 16.82% ROE has changed -98.76% with respect to the historical average. Over the past ten years (40 quarters), RGBP's ROE was at its highest in in the December 2015 quarter at 8.45%. The ROE was at its lowest in in the March 2015 quarter at -2484.33%.
Average
1.36%
Median
52.29%
Minimum
-68.32%
Maximum
11.52%
Discovering the peaks and valleys of Regen BioPharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.87%
Maximum Annual ROE = 11.52%
Minimum Annual Increase = -316.88%
Minimum Annual ROE = -68.32%
Year | ROE | Change |
---|---|---|
2023 | -20.05% | -70.65% |
2022 | -68.32% | -229.18% |
2021 | 52.89% | -316.88% |
2020 | -24.38% | -161.52% |
2019 | 39.64% | -23.32% |
2018 | 51.69% | -53.51% |
2017 | 111.19% | -91.58% |
2016 | 1.32% | -88.54% |
2015 | 11.52% | 1.87% |
2014 | 583.47% | -290.51% |
The current ROE of Regen BioPharma, Inc. (RGBP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-11.83%
5-year avg
-4.05%
10-year avg
1.36%
Regen BioPharma, Inc.’s ROE is greater than Oncology Pharma Inc. (0%), less than Propanc Biopharma, Inc. (63.02%), greater than Kaleido Biosciences, Inc. (0%), greater than RegeneRx Biopharmaceuticals, Inc. (0%), greater than Creative Medical Technology Holdings, Inc. (-58.37%), greater than Theralink Technologies, Inc. (-41.95%), less than Enzolytics Inc. (93.13%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), less than PharmaTher Holdings Ltd. (0%), greater than Regen BioPharma, Inc. (-102.91%), less than Mymetics Corporation (16.82%), less than ProtoKinetix, Incorporated (15.72%), greater than Adynxx, Inc. (-87.94%), less than Ascletis Pharma Inc. (0%), greater than Eupraxia Pharmaceuticals Inc. (0%), greater than AVAX Technologies, Inc. (-0.89%), greater than null (-198.59%), greater than null (-344.15%),
Company | ROE | Market cap |
---|---|---|
0% | $273.90K | |
63.02% | $180.86K | |
0% | $4.26K | |
0% | $2.10K | |
-58.37% | $6.14M | |
-41.95% | $615.15K | |
93.13% | $7.19M | |
-398.33% | $2.96M | |
0% | $15.23M | |
-102.91% | $14.55M | |
16.82% | $303.76K | |
15.72% | $3.94M | |
-87.94% | $581.00 | |
0% | $154.30M | |
0% | $108.29M | |
-0.89% | $6.89K | |
-198.59% | $0 | |
-344.15% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regen BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Regen BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Regen BioPharma, Inc.'s ROE?
How is the ROE calculated for Regen BioPharma, Inc. (RGBP)?
What is the highest ROE for Regen BioPharma, Inc. (RGBP)?
What is the 3-year average ROE for Regen BioPharma, Inc. (RGBP)?
What is the 5-year average ROE for Regen BioPharma, Inc. (RGBP)?
How does the current ROE for Regen BioPharma, Inc. (RGBP) compare to its historical average?